DINGHong-fan 1 # , WUQiong-fang 2 # , YANGNan 3 , DENGWei 1 , WANGQi 4,5,6 , YAOLiang 4,5,6 , WANGXiao-qin 4,5,6 , WEIDang 4,5,6 , CHENYao-long 4,5,6 , DULiang 7
  • 1. The Second Clinical Medical School, Lanzhou University, Lanzhou 730000, China;
  • 2. Department of Anesthesiology, Peking University First Hospital, Beijing 100034 China;
  • 3. The First Clinical Medical School, Lanzhou University, Lanzhou 730000, China;
  • 4. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China;
  • Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, China;
  • 6. Chinese GRADE Center, Lanzhou University, Lanzhou 730000, China;
  • 7. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China;
CHENYao-long, Email: chenyaolong21@163.com; DULiang, Email: duliang0606@vip.sina.com
Export PDF Favorites Scan Get Citation

Objective To interpret ROBIS, a new tool to evaluate the risk of bias in systematic reviews, to promote the comprehension of it and its proper application. Methods We explained each item of ROBIS tool, used it to evaluate the risk of bias of a selected intervention review whose title was Cyclophosphamide for Primary Nephrotic Syndrome of Children: A Systematic Review, and judged the risk of bias in the review. Results The selected systematic review as a whole was rated as “high risk of bias”, because there existed high risk of bias in domain 2 to 4, namely identification and selection of studies, data collection and study appraisal, synthesis and findings. The risk of bias in domain 1 (study eligibility criteria) was low. The relevance of identified studies and the review’s research question was appropriately considered and the reviewers avoided emphasizing results on the basis of their statistical significance. Conclusion ROBIS is a new tool worthy of being recommended to evaluate risk of bias in systematic reviews. Reviewers should use ROBIS items as standards to conduct and produce high quality systematic reviews.

Citation: DINGHong-fan, WUQiong-fang, YANGNan, DENGWei, WANGQi, YAOLiang, WANGXiao-qin, WEIDang, CHENYao-long, DULiang. Interpretation of ROBIS Tool in Evaluating the Risk of Bias of a Selected Systematic Review. Chinese Journal of Evidence-Based Medicine, 2016, 16(1): 115-121. doi: 10.7507/1672-2531.20160021 Copy

  • Previous Article

    How to Conduct Dose-response Meta-analysis by Using Linear relation and Piecewise Linear Regression Model
  • Next Article

    The Origin and Development of Evidence-based Medicine in China:The 20th Anniversary of the Introduction of Evidence-based Medicine to China